Showing results (321-330 of 3,163) with videos related to

Sort By:
Pageof 317
Translational Oncology|June 12, 2021
Anti-tumor effects of rigosertib in high-risk neuroblastomaKatarzyna Radke, Karin Hansson, Jonas Sjölund, et al.
Translational Oncology|May 17, 2014
Rad6 is a Potential Early Marker of Melanoma DevelopmentKarli Rosner, Shreelekha Adsule, Brittany Haynes, et al.
Translational Oncology|May 17, 2014
Expression of the Androgen Receptor, pAkt, and pPTEN in Breast Cancer and Their Potential in PrognosticationAisha Sultana, Romana Idress, Zulfiqar Ali Naqvi, et al.
Translational Oncology|March 10, 2015
A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal CancerPhilip W Voorneveld, Rutger J Jacobs, Liudmila L Kodach, et al.
Translational Oncology|March 10, 2015
Targeting mcl-1 for radiosensitization of pancreatic cancersDongping Wei, Qiang Zhang, Jason S Schreiber, et al.
Translational Oncology|March 10, 2015
Determining the Variability of Lesion Size Measurements from CT Patient Data Sets Acquired under "No Change" ConditionsMichael F McNitt-Gray, Grace Hyun Kim, Binsheng Zhao, et al.
Translational Oncology|April 16, 2023
Unraveling the Post-Translational Modifications and therapeutical approach in NSCLC pathogenesisPooja Gulhane, Shailza Singh
Translational Oncology|April 17, 2023
Loss of BLK expression as a potential predictor of poor prognosis and immune checkpoint blockade response in NSCLC and contribute to tumor progressionYingqi Xu, Jianlin Xu, Rong Qiao, et al.
Translational Oncology|May 3, 2023
Matrix stiffness induces an invasive-dormant subpopulation via cGAS-STING axis in oral cancerLi Jingyuan, Liu Yu, Jiang Hong, et al.
Translational Oncology|May 7, 2023
High Expression of Tumor HLA-DR Predicts Better Prognosis and Response to Anti-PD-1 Therapy in Laryngeal Squamous Cell CarcinomaYu Heng, Xiaoke Zhu, Qian Wu, et al.
Pageof 317